Biotech News
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences:
